Contents

Search

emtricitabine/rilpivirine/tenofovir DF (FTC/RPV/TDF, TAF/FTC/RPV, Complera, Odefsey)

Indications: - treatment-naive HIV-infected patients Dosage: - once daily dosing Odefsey: (smallest pill of any single tablet) [3] - emtricitabine 200 mg - rilpivirine 25 mg - tenofovir alafenamide (TAF; 25 mg) Storage: - store in orginal container - must be protected from moisture - original container has a desiccant [2]

General

antiretroviral combination

References

  1. FDA: August 10, 2011 Approval of Complera: emtricitabine/rilpivirine/tenofovir DF fixed dose combination http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm267592.htm
  2. Prescriber's Letter 21(6): 2014 Oral Meds to Keep in Original Containers Detail-Document#: 300622 (subscription needed) http://www.prescribersletter.com
  3. Brooks M Medscape. March 2, 2016 FDA Clears Gilead's Second TAF-Based HIV Regimen (Odefsey) http://www.medscape.com/viewarticle/859730

Components

emtricitabine (Emtriva, FTC) rilpivirine (Edurant, RPV) tenofovir (TDF)